The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: Both nonselective and selective nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to increase blood pressure (BP). Objective: This review summarizes the most recent data regarding the BP changes that may occur with routine dosing of nonselective or selective NSAIDs, with a focus on the latter. The review includes both clinical trials and studies having more naturalistic designs. Methods: Relevant articles were identified through a search of MEDLINE emphasizing NSAIDs and hypertension. Results: It is well established that NSAIDs increase BP in certain patients. Patients with existing hypertension seem to be at greatest risk for this adverse event. There seem to be differences between nonselective NSAIDs with regard to their effect on BP; indomethacin, naproxen, and piroxicam have been associated with clinically significant changes in BP. Most of the available evidence concerning the selective NSAIDs suggests that rofecoxib is more likely than celecoxib to raise systolic BP. Based on the results of trials in the treatment of BP, increases in systolic BP produced by these NSAIDs may be associated with significant morbidity and mortality. The adverse effects of NSAIDs on BP may be related to the specific drug or to the dose or duration of therapy, as well as to patient-specific characteristics. Conclusions: Clinically significant BP changes may occur after treatment with either nonselective or selective NSAIDs. The observed BP changes are not the same for ali products, however.

Original languageEnglish (US)
Pages (from-to)1-18
Number of pages18
JournalClinical Therapeutics
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Anti-Inflammatory Agents
Blood Pressure
Pharmaceutical Preparations
Celecoxib
Hypertension
Piroxicam
Naproxen
MEDLINE
Indomethacin
Therapeutics
Clinical Trials
Morbidity
Mortality

Keywords

  • Celecoxib
  • Hypertension
  • Indomethacin
  • Naproxen
  • Nonsteroidal anti-inflammatory drug
  • Piroxicam
  • Rofecoxib

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{e1f3d49690e144c68acf7ca55a647ae7,
title = "The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents",
abstract = "Background: Both nonselective and selective nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to increase blood pressure (BP). Objective: This review summarizes the most recent data regarding the BP changes that may occur with routine dosing of nonselective or selective NSAIDs, with a focus on the latter. The review includes both clinical trials and studies having more naturalistic designs. Methods: Relevant articles were identified through a search of MEDLINE emphasizing NSAIDs and hypertension. Results: It is well established that NSAIDs increase BP in certain patients. Patients with existing hypertension seem to be at greatest risk for this adverse event. There seem to be differences between nonselective NSAIDs with regard to their effect on BP; indomethacin, naproxen, and piroxicam have been associated with clinically significant changes in BP. Most of the available evidence concerning the selective NSAIDs suggests that rofecoxib is more likely than celecoxib to raise systolic BP. Based on the results of trials in the treatment of BP, increases in systolic BP produced by these NSAIDs may be associated with significant morbidity and mortality. The adverse effects of NSAIDs on BP may be related to the specific drug or to the dose or duration of therapy, as well as to patient-specific characteristics. Conclusions: Clinically significant BP changes may occur after treatment with either nonselective or selective NSAIDs. The observed BP changes are not the same for ali products, however.",
keywords = "Celecoxib, Hypertension, Indomethacin, Naproxen, Nonsteroidal anti-inflammatory drug, Piroxicam, Rofecoxib",
author = "Armstrong, {Edward P} and Malone, {Daniel C}",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0149-2918(03)90003-8",
language = "English (US)",
volume = "25",
pages = "1--18",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "1",

}

TY - JOUR

T1 - The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents

AU - Armstrong, Edward P

AU - Malone, Daniel C

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Background: Both nonselective and selective nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to increase blood pressure (BP). Objective: This review summarizes the most recent data regarding the BP changes that may occur with routine dosing of nonselective or selective NSAIDs, with a focus on the latter. The review includes both clinical trials and studies having more naturalistic designs. Methods: Relevant articles were identified through a search of MEDLINE emphasizing NSAIDs and hypertension. Results: It is well established that NSAIDs increase BP in certain patients. Patients with existing hypertension seem to be at greatest risk for this adverse event. There seem to be differences between nonselective NSAIDs with regard to their effect on BP; indomethacin, naproxen, and piroxicam have been associated with clinically significant changes in BP. Most of the available evidence concerning the selective NSAIDs suggests that rofecoxib is more likely than celecoxib to raise systolic BP. Based on the results of trials in the treatment of BP, increases in systolic BP produced by these NSAIDs may be associated with significant morbidity and mortality. The adverse effects of NSAIDs on BP may be related to the specific drug or to the dose or duration of therapy, as well as to patient-specific characteristics. Conclusions: Clinically significant BP changes may occur after treatment with either nonselective or selective NSAIDs. The observed BP changes are not the same for ali products, however.

AB - Background: Both nonselective and selective nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to increase blood pressure (BP). Objective: This review summarizes the most recent data regarding the BP changes that may occur with routine dosing of nonselective or selective NSAIDs, with a focus on the latter. The review includes both clinical trials and studies having more naturalistic designs. Methods: Relevant articles were identified through a search of MEDLINE emphasizing NSAIDs and hypertension. Results: It is well established that NSAIDs increase BP in certain patients. Patients with existing hypertension seem to be at greatest risk for this adverse event. There seem to be differences between nonselective NSAIDs with regard to their effect on BP; indomethacin, naproxen, and piroxicam have been associated with clinically significant changes in BP. Most of the available evidence concerning the selective NSAIDs suggests that rofecoxib is more likely than celecoxib to raise systolic BP. Based on the results of trials in the treatment of BP, increases in systolic BP produced by these NSAIDs may be associated with significant morbidity and mortality. The adverse effects of NSAIDs on BP may be related to the specific drug or to the dose or duration of therapy, as well as to patient-specific characteristics. Conclusions: Clinically significant BP changes may occur after treatment with either nonselective or selective NSAIDs. The observed BP changes are not the same for ali products, however.

KW - Celecoxib

KW - Hypertension

KW - Indomethacin

KW - Naproxen

KW - Nonsteroidal anti-inflammatory drug

KW - Piroxicam

KW - Rofecoxib

UR - http://www.scopus.com/inward/record.url?scp=0037276729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037276729&partnerID=8YFLogxK

U2 - 10.1016/S0149-2918(03)90003-8

DO - 10.1016/S0149-2918(03)90003-8

M3 - Article

C2 - 12637109

AN - SCOPUS:0037276729

VL - 25

SP - 1

EP - 18

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 1

ER -